BEAM
Beam Therapeutics Inc.
+1.78 (+7.71%)24.88USD1.2M成交股數2.6B市值–本益比(近四季)16.5股價營收比-94.2%營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 8 · 12.2M · 3 |
| 其中 10b5-1 計畫賣出 | 6 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 14.8M |
| 近 180 天 淨額 | −14.8M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 | 07-29 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 16.7K | 25.74 | 429K | 85.7K | SEC |
| 2026-06-30 | 07-02 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 373 | 34.73 | 13K | 102K | SEC |
| 2026-06-30 | 07-01 | Evans John M. | CEO | M 選擇權執行 | 25.0K | 1.03 | 26K | 1.1M | SEC |
| 2026-06-30 | 07-01 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 1.9K | 34.84 | 66K | 1.0M | SEC |
| 2026-06-30 | 07-01 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 23.1K | 34.26 | 791K | 1.0M | SEC |
| 2026-06-29 | 07-01 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 11.6K | 35.91 | 416K | 1.0M | SEC |
| 2026-06-29 | 07-01 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 13.4K | 35.13 | 472K | 1.1M | SEC |
| 2026-06-29 | 07-01 | Evans John M. | CEO | M 選擇權執行 | 18.7K | 0.67 | 13K | 1.1M | SEC |
| 2026-06-29 | 07-01 | Evans John M. | CEO | M 選擇權執行 | 6.3K | 1.03 | 7K | 1.1M | SEC |
| 2026-06-26 | 06-29 | FMR LLC | TenPercentOwner,Other | S 公開市場賣出 | 251K | 35.26 | 8.9M | 855K | SEC |
| 2026-06-25 | 06-29 | FMR LLC | TenPercentOwner,Other | S 公開市場賣出 | 33.4K | 35.12 | 1.2M | 1.1M | SEC |
| 2026-06-17 | 06-22 | Ciaramella Giuseppe | President | M 選擇權執行 | 6.5K | 0.67 | 4K | 225K | SEC |
| 2026-06-17 | 06-22 | Ciaramella Giuseppe | President | M 選擇權執行 | 29.0K | 1.03 | 30K | 254K | SEC |
| 2026-04-01 | 04-06 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 6.0K | 24.58 | 146K | 110K | SEC |
| 2026-04-01 | 04-06 | Ciaramella Giuseppe | President | S 公開市場賣出(10b5-1) | 11.8K | 24.58 | 290K | 218K | SEC |
| 2026-04-01 | 04-06 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 6.7K | 24.58 | 165K | 103K | SEC |
| 2026-04-01 | 04-06 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 30.1K | 24.58 | 739K | 1.0M | SEC |
| 2026-04-01 | 04-06 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 3.2K | 24.58 | 80K | 51.2K | SEC |
| 2026-03-31 | 04-02 | Ciaramella Giuseppe | President | A 獲配股票 | 40.0K | – | – | 230K | SEC |
| 2026-03-31 | 04-02 | Cavanagh Bethany J | SVP, Finance and Treasurer | A 獲配股票 | 20.0K | – | – | 54.8K | SEC |
| 2026-03-31 | 04-02 | Bellon Christine | Chief Legal Officer | A 獲配股票 | 20.0K | – | – | 116K | SEC |
| 2026-03-31 | 04-02 | Simon Amy | Chief Medical Officer | A 獲配股票 | 31.8K | – | – | 109K | SEC |
| 2026-03-31 | 04-02 | Emany Sravan Kumar | Chief Financial Officer | A 獲配股票 | 31.8K | – | – | 105K | SEC |
| 2026-03-31 | 04-01 | Evans John M. | CEO | A 獲配股票 | 90.0K | – | – | 1.1M | SEC |
| 2026-03-31 | 04-01 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 25.0K | 22.76 | 569K | 987K | SEC |
| 2026-03-31 | 04-01 | Evans John M. | CEO | M 選擇權執行 | 25.0K | 0.67 | 17K | 1.0M | SEC |
| 2026-03-30 | 04-01 | Evans John M. | CEO | M 選擇權執行 | 25.0K | 0.67 | 17K | 1.0M | SEC |
| 2026-03-30 | 04-01 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 25.0K | 22.37 | 559K | 987K | SEC |
| 2026-02-24 | 02-26 | Ciaramella Giuseppe | President | S 公開市場賣出(10b5-1) | 35.0K | 32.00 | 1.1M | 190K | SEC |
| 2026-02-24 | 02-26 | Ciaramella Giuseppe | President | M 選擇權執行 | 35.0K | 17.00 | 595K | 225K | SEC |
| 2026-01-30 | 02-02 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 2.9K | 29.00 | 84K | 987K | SEC |
| 2026-01-30 | 02-02 | Evans John M. | CEO | M 選擇權執行 | 25.0K | 0.67 | 17K | 1.0M | SEC |
| 2026-01-30 | 02-02 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 22.1K | 28.27 | 625K | 990K | SEC |
| 2026-01-29 | 02-02 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 16.3K | 29.19 | 477K | 995K | SEC |
| 2026-01-29 | 02-02 | Evans John M. | CEO | M 選擇權執行 | 5.7K | 0.67 | 4K | 1.0M | SEC |
| 2026-01-29 | 02-02 | Evans John M. | CEO | M 選擇權執行 | 19.3K | 0.67 | 13K | 1.0M | SEC |
| 2026-01-29 | 02-02 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 8.7K | 29.74 | 258K | 987K | SEC |
| 2026-01-22 | 01-26 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.4K | 34.00 | 47K | 95.7K | SEC |
| 2026-01-22 | 01-26 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 6.2K | 35.00 | 217K | 34.8K | SEC |
| 2026-01-20 | 01-21 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 3.0K | 30.12 | 91K | 41.0K | SEC |
| 2026-01-15 | 01-20 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 2.1K | 33.62 | 71K | 114K | SEC |
| 2026-01-15 | 01-20 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 559 | 35.40 | 20K | 97.0K | SEC |
| 2026-01-15 | 01-20 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 16.0K | 34.72 | 554K | 97.6K | SEC |
| 2025-12-31 | 01-05 | Emany Sravan Kumar | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.3K | 27.10 | 171K | 73.7K | SEC |
| 2025-12-31 | 01-05 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.3K | 27.10 | 34K | 116K | SEC |
| 2025-12-31 | 01-05 | Simon Amy | Chief Medical Officer | A 獲配股票 | 12.5K | – | – | 77.4K | SEC |
| 2025-10-27 | 10-29 | FMR LLC | TenPercentOwner,Other | S 公開市場賣出 | 459 | 26.68 | 12K | 14 | SEC |
| 2025-10-06 | 10-08 | FMR LLC | TenPercentOwner,Other | G 贈與 | 1.2M | – | – | 841K | SEC |
| 2025-10-02 | 10-03 | Evans John M. | CEO | M 選擇權執行 | 25.0K | 0.67 | 17K | 1.0M | SEC |
| 2025-10-02 | 10-03 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 25.0K | 24.63 | 616K | 987K | SEC |
| 2025-10-01 | 10-03 | Evans John M. | CEO | M 選擇權執行 | 25.0K | 0.67 | 17K | 1.0M | SEC |
| 2025-10-01 | 10-03 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 467 | 24.53 | 11K | 44.0K | SEC |
| 2025-10-01 | 10-03 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 373 | 24.53 | 9K | 117K | SEC |
| 2025-10-01 | 10-03 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 25.0K | 24.51 | 613K | 987K | SEC |
| 2025-07-30 | 08-01 | FMR LLC | TenPercentOwner,Other | S 公開市場賣出 | 48.4K | 20.50 | 992K | 2.1M | SEC |
| 2025-07-03 | 07-03 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 876 | 20.12 | 18K | 64.9K | SEC |
| 2025-07-01 | 07-03 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 374 | 16.94 | 6K | 65.7K | SEC |
| 2025-04-02 | 04-03 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 21.0K | 17.73 | 372K | 65.7K | SEC |
| 2025-04-01 | 04-03 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 5.7K | 18.35 | 104K | 117K | SEC |
| 2025-04-01 | 04-03 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 30.7K | 18.35 | 563K | 986K | SEC |
| 2025-04-01 | 04-03 | Ciaramella Giuseppe | President | S 公開市場賣出(10b5-1) | 7.4K | 18.35 | 136K | 190K | SEC |
| 2025-04-01 | 04-03 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 3.0K | 18.35 | 55K | 44.5K | SEC |
| 2025-04-01 | 04-03 | Simon Amy | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.6K | 18.35 | 176K | 86.7K | SEC |
| 2025-03-31 | 04-02 | Ciaramella Giuseppe | President | A 獲配股票 | 35.0K | – | – | 198K | SEC |
| 2025-03-31 | 04-02 | Bellon Christine | Chief Legal Officer | A 獲配股票 | 20.0K | – | – | 123K | SEC |
| 2025-03-31 | 04-02 | Cavanagh Bethany J | SVP, Finance and Treasurer | A 獲配股票 | 10.0K | – | – | 47.5K | SEC |
| 2025-03-31 | 04-02 | Evans John M. | CEO | A 獲配股票 | 77.5K | – | – | 1.0M | SEC |
| 2025-03-31 | 04-02 | Simon Amy | Chief Medical Officer | A 獲配股票 | 27.5K | – | – | 96.3K | SEC |
| 2025-02-18 | 02-20 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 6.3K | 35.00 | 220K | 37.5K | SEC |
| 2025-02-14 | 02-19 | Bellon Christine | Chief Legal Officer | M 選擇權執行 | 9.5K | 7.22 | 69K | 112K | SEC |
| 2025-02-14 | 02-19 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 10.0K | 34.00 | 340K | 103K | SEC |
| 2025-02-14 | 02-19 | Bellon Christine | Chief Legal Officer | M 選擇權執行 | 508 | 7.22 | 4K | 113K | SEC |
| 2025-01-30 | 04-02 | Evans John M. | CEO | M 選擇權執行 | 30.0K | 0.67 | 20K | 969K | SEC |
| 2025-01-30 | 02-03 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 200 | 27.28 | 5K | 909K | SEC |
| 2025-01-30 | 02-03 | Evans John M. | CEO | S 公開市場賣出(10b5-1) | 29.8K | 26.75 | 797K | 909K | SEC |
| 2025-01-02 | 01-06 | Bellon Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.2K | 24.68 | 31K | 103K | SEC |
| 2025-01-02 | 01-06 | Cavanagh Bethany J | SVP, Finance and Treasurer | S 公開市場賣出(10b5-1) | 1.1K | 24.68 | 28K | 43.8K | SEC |
| 2024-12-31 | 01-02 | Emany Sravan Kumar | Chief Financial Officer | A 獲配股票 | 80.0K | – | – | 80.0K | SEC |
| 2024-12-17 | 12-19 | Ciaramella Giuseppe | President | M 選擇權執行 | 53.5K | 0.67 | 36K | 163K | SEC |
| 2024-11-06 | 11-08 | Ciaramella Giuseppe | President | S 公開市場賣出(10b5-1) | 51.1K | 26.36 | 1.3M | 109K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 12.6M | 433M | 新進 | 新進 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 10.2M | 351M | 新進 | 新進 |
| 方舟(伍德) ARK Investment Management LLC | 10.2M | 351M | 新進 | 新進 |
| BlackRock, Inc. | 9.0M | 309M | 新進 | 新進 |
| STATE STREET CORP | 5.8M | 200M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | 169M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | 158M | 新進 | 新進 |
| ARCH Venture Management, LLC | 4.5M | 156M | 新進 | 新進 |
| Sumitomo Mitsui Trust Group, Inc. | 3.5M | 119M | 新進 | 新進 |
| Amova Asset Management Americas, Inc. | 3.5M | 119M | 新進 | 新進 |
| Kynam Capital Management, LP | 2.8M | 97.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6M | 89.1M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.2M | 76.4M | 新進 | 新進 |
| MORGAN STANLEY | 2.0M | 67.0M | 新進 | 新進 |
| Contrarius Group Holdings Ltd | 1.6M | 55.4M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.6M | 53.3M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.4M | 47.6M | 新進 | 新進 |
| Casdin Capital, LLC | 1.4M | 46.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.3M | 45.0M | 新進 | 新進 |
| Redmile Group, LLC | 1.2M | 40.0M | 新進 | 新進 |
| BNP PARIBAS FINANCIAL MARKETS | 1.1M | 36.6M | 新進 | 新進 |
| Deep Track Capital, LP | 1.0M | 34.3M | 新進 | 新進 |
| NORTHERN TRUST CORP | 933K | 32.0M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 886K | 30.4M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 721K | 24.7M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 277 +24 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 277 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 109M · 100.0% |
| 合計季末市值 | 3.6B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 25.8M |
|---|---|
| 與上期比 | +5.9% |
| 佔流通股數 | 24.98% |
| 日均成交量 | 1.7M |
| 回補天數 | 14.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 25.8M | +5.9% | 24.98% | 1.7M | 14.8 |
| 2026-08-14 | 24.4M | +3.7% | 23.60% | 1.5M | 16.1 |
| 2026-07-31 | 23.5M | +1.2% | 22.75% | 2.1M | 11.3 |
| 2026-07-15 | 23.2M | +1.5% | 22.48% | 2.6M | 8.9 |
| 2026-06-30 | 22.9M | -19.2% | 22.15% | 2.7M | 8.4 |
| 2026-06-15 | 28.3M | +31.9% | 27.41% | 2.0M | 14.2 |
| 2026-05-29 | 21.5M | -19.1% | 20.77% | 1.8M | 11.7 |
| 2026-05-15 | 26.5M | +26.6% | 25.67% | 2.1M | 12.6 |
| 2026-04-30 | 20.9M | -5.8% | 20.27% | 2.2M | 9.5 |
| 2026-04-15 | 22.2M | -4.9% | 21.51% | 2.0M | 11.1 |
| 2026-03-31 | 23.4M | +9.7% | 22.62% | 2.2M | 10.7 |
| 2026-03-13 | 21.3M | -2.7% | 20.62% | 2.0M | 10.6 |
| 2026-02-27 | 21.9M | +8.2% | 21.19% | 1.6M | 13.6 |
| 2026-02-13 | 20.2M | +4.2% | 19.58% | 1.5M | 13.5 |
| 2026-01-30 | 19.4M | -3.2% | 18.79% | 1.9M | 10.1 |
| 2026-01-15 | 20.0M | -1.2% | 19.41% | 2.3M | 8.6 |
| 2025-12-31 | 20.3M | +2.6% | 19.65% | 1.3M | 15.7 |
| 2025-12-15 | 19.8M | -5.5% | 19.16% | 1.8M | 10.9 |
| 2025-11-28 | 21.0M | +1.9% | 20.28% | 2.0M | 10.4 |
| 2025-11-14 | 20.6M | +3.7% | 19.90% | 2.4M | 8.7 |
| 2025-10-31 | 19.8M | -2.9% | 19.19% | 2.6M | 7.6 |
| 2025-10-15 | 20.4M | -4.5% | 19.77% | 2.4M | 8.4 |
| 2025-09-30 | 21.4M | -16.2% | 20.70% | 2.5M | 8.5 |
| 2025-09-15 | 25.5M | +0.1% | 24.69% | 3.5M | 7.3 |
| 2025-08-29 | 25.5M | -6.2% | 24.67% | 2.2M | 11.5 |
| 2025-08-15 | 27.2M | +10.4% | 26.31% | 2.5M | 10.7 |